Dawn it-Tliet Teknoloġiji tas-Saħħa ta 'Sejbien ta' Toilets Se jiġu Ittestjati Klinikament Fl-Istati Uniti, Iżrael U l-Ġappun

Dawn it-Tliet Teknoloġiji tas-Saħħa ta 'Sejbien ta' Toilets Se jiġu Ittestjati Klinikament Fl-Istati Uniti, Iżrael U l-Ġappun

Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 Ġunju. The technology gains life-saving medical insights by analysing human excrement. Il-kumpanija ressqet serje ta 'tliet privattivi li jkopru elementi tas-sensorju tat-twaletta medika tagħha.

Three Toilets Detection Health Technologies

The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Ewropa, Ġappun u ċ-Ċina.

A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, It-teknoloġija ta 'OutSense tista' tidentifika s-sors tad-demm tul il-passaġġ gastrointestinali.

A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

Skont il-Kap Eżekuttiv ta 'OutSense Yfat Scialom, who predicts that “bl-isplużjoni tal-mediċina diġitali, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, mard infjammatorju tal-musrana u infezzjonijiet fl-apparat urinarju.

Its solution consists of a multispectral optical sensor, sors tad-dawl u apparat ta' screening awtonomu li jinkludi konnessjoni WiFi. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.

OutSense has developed tools to diagnose abnormalities in human excreta. Informazzjoni miksuba minn demm kampjun, flimkien ma' analiżi addizzjonali taż-żmien mill-fsada sat-tneħħija, jipprovdi dettalji tal-patoloġija tal-fsada. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.

At the beginning of June, OutSense ħabbar li CommuniCare, kumpanija kbira tal-kura tas-saħħa b'aktar minn 90 healthcare facilities in the US, se jibda jmexxi t-teknoloġija tiegħu din is-sena. Minbarra dan il-pilota, OutSense also plans to conduct clinical trials in Israel and Japan.

Żur Aktar Aħbarijiet fuq Viga.cc Aħbarijiet